医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Antigenic analysis of the influenza B virus hemagglutinin protein

摘要Influenza B viruses(IBVs)primarily infect humans and are a common cause of respiratory infections in humans.Here,to systematically analyze the antigenicity of the IBVs Hemagglutinin(HA)protein,31 B/Victoria and 19 B/Yamagata representative circulating strains were selected from Global Initiative of Sharing All Influenza Data(GISAID),and pseudotyped viruses were constructed with the vesicular sto-matitis virus system.Guinea pigs were immunized with three doses of vaccines(one dose of DNA vaccines following two doses of pseudotyped virus vaccines)of the seven IBV vaccine strains,and neutralizing antibodies against the pseudotyped viruses were tested.By comparing differences between various vaccine strains,we constructed several pseudotyped viruses that contained various mutations based on vaccine strain BV-21.The vaccine strains showed good neutralization levels against the epidemic virus strains of the same year,with neutralization titers ranging from 370 to 840,while the level of neutralization against viruses prevalent in previous years decreased 1-10-fold.Each of the high-frequency epidemic strains of B/Victoria and B/Yamagata not only induced high neutralizing titers,but also had broadly neutralizing effects against virus strains of different years,with neutralizing titers ranging from 1000 to 7200.R141G,D197 N,and R203K were identified as affecting the antigenicity of IBV.These mutation sites provide valuable references for the selection and design of a universal IBV vaccine strain in the future.

更多
广告
作者 Mengyi Zhang [1] Chaoying Yang [2] Xi Wu [3] Yifei Wang [3] Lijie Wang [3] Qianqian Cui [3] Jincheng Tong [3] Yimeng An [3] Meina Cai [3] Shishi Cheng [3] Qi Jiang [3] Yulin Wang [4] Chenyan Zhao [3] Youchun Wang [5] Weijin Huang [1] 学术成果认领
作者单位 Division of HIV/AIDS and Sex-Transmitted Virus Vaccines,Institute for Biological Product Control,National Institutes for Food and Drug Control(NIFDC),Beijing,102629,China;National Institutes for Food and Drug Control,Chinese Academy of Medical Science & Peking Union Medical College,Beijing,100730,China [1] Division of HIV/AIDS and Sex-Transmitted Virus Vaccines,Institute for Biological Product Control,National Institutes for Food and Drug Control(NIFDC),Beijing,102629,China;National Vaccine & Serum Institute,Beijing 101111,China [2] Division of HIV/AIDS and Sex-Transmitted Virus Vaccines,Institute for Biological Product Control,National Institutes for Food and Drug Control(NIFDC),Beijing,102629,China [3] National Vaccine & Serum Institute,Beijing 101111,China [4] Institute of Medical Biology,Chinese Academy of Medical Science & Peking Union Medical College,Kunming,650031,China [5]
栏目名称
DOI 10.1016/j.virs.2024.08.012
发布时间 2025-05-06(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览3
  • 下载0
中国病毒学

中国病毒学

2025年40卷1期

80-91页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷